DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR MS Speaks
       *****************************************************
   DIR Alemtuzumab under scrutiny because of risk of stroke in some p...
       0 replies
   DIR (Abst.) Autoimmune nephropathies after Lemtrada treatment in P...
       0 replies
   DIR (Abst.) Immune profiling of a patient w/alemtuzumab-associated...
       0 replies
   DIR (Abst.) Neutropenia w/fatal outcome in MS patient 23 days afte...
       0 replies
   DIR More risks emerge for alemtuzumab in MS
       0 replies
   DIR (Absts.) Two adverse events with Lemtrada reported
       0 replies
   DIR (Abst.) Decreased platelet number in MS during alemtuzumab inf...
       0 replies
   DIR (Abst.) Activation of MS during Lemtrada therapy in 3 patients...
       0 replies
   DIR (Abst.) Alemtuzumab in MS: Lessons from social media in enhanc...
       0 replies
   DIR Induction of new autoimmune diseases after alemtuzumab therapy...
       0 replies
       *****************************************************
   DIR Next Page